Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CME (CME)

CME Group Q1 2025 revenue rises 10% to $1.6 billion; diluted EPS $2.62

Positive Impact 3 of 5 earnings Written later

CME Group reported first-quarter 2025 results, with revenue of $1.6 billion, up 10% from a year earlier, and GAAP diluted earnings per share of $2.62 versus $2.35. Adjusted diluted EPS was $2.80 versus $2.50, and average daily volume reached a record 29.8 million contracts. The release does not include updated forward guidance.

Key points

  • Total revenues of $1,642.3 million for the quarter ended March 31, 2025, up 10% from the prior year
  • GAAP net income of $956.2 million versus $855.2 million; diluted EPS $2.62 versus $2.35
  • Adjusted diluted EPS of $2.80 versus $2.50 in the first quarter of 2024
  • Average daily volume of 29.8 million contracts; cash of $1.6 billion and long-term debt of $3.4 billion at March 31, 2025

The filing

CompanyCME (CME)
Form8-K, current report
Filed with the SECApr 23, 2025, 7:07 AM ET
Accession number0001156375-25-000093

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 23, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.